Waters Lowers Fourth-Quarter Forecast
This announcement was a bellweather of sorts, triggering downgrades by analysts of several instrument companies, as well as sharp declines in instrument companies’ stock prices. Forecasts for the slowing growth of the chemical, pharmaceutical and other industries have dimmed prospects for analytical instrument sales in general.
Milford, MA 12/11/08—Waters has lowered its revenue and non-GAAP EPS forecast for the fourth quarter as a result of weaker than expected instrument orders and deteriorating economic conditions. The company now expects fourth-quarter sales to decline 4%–6% to $410–$420 million, including negative currency effects of approximately 4%. Previous guidance was approximately $454 million in sales, representing 4% growth, including a negative 2% impact from foreign currency translations. Fourth-quarter non-GAAP EPS is now forecasted to be $0.94–$0.99, compared to a previous forecast of $1.08–$1.12. “Global economic conditions have weakened since our October conference call and we now see a generally more difficult business environment ahead of us. Capital spending is more constrained as our customers are more cautious given the recent economic turbulence in many regions of the world,” stated President and CEO Douglas A. Berthiaume. “Additionally, foreign exchange impacts are unfavorably affecting our business growth and profitability. These conditions are likely to continue into next year and we are presently assessing our spending plans to align with lower sales expectations going forward.”

